ZNZhenhua Niu

Zhenhua Niu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhenhua Niu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial

    by Wentao Gu, Zhenhua Niu, Qisijing Liu, Haitao Wang, Miao Yu, Meiying Xu, Xuemeng Ji, Dancai Fan, Jin Wang, Yanrong Zhao, et al.

    Background: Activity-related knee discomfort is common in endurance-trained adults. Multi-ingredient supplements targeting complementary biological pathways may support knee comfort and load tolerance in this population, but controlled evidence is limited. Methods: In this randomized, double-blind, placebo- and active-comparator-controlled pilot trial, 60 endurance-trained adults (20 per group) with activity-related knee discomfort received for 12 weeks either a multi-ingredient formula (undenatured type II collagen, curcumin phytosome, and enzymatically hydrolyzed bone powder; Group A), glucosamine hydrochloride plus chondroitin sulfate (Group B), or placebo (Group C). Assessments of functional and patient-reported outcomes were conducted at baseline, week 6, week 12, and 24 h after a post-intervention half-marathon challenge. Outcome measures covered functional pain tolerance, patient-reported pain symptoms, exploratory biomarkers of cartilage turnover, inflammation, and oxidative stress. Results: Group-by-time interactions were significant for SLSD repetitions to pain levels 2 and 5 and for VAS (all p < 0.0001). At week 12, Group A exceeded placebo for the SLSD repetitions to pain level 5 (mean difference 30.5 repetitions; 95% CI 8.7 to 52.3; p = 0.0201), for SLSD repetitions to pain level 2 (21.4; 8.8 to 34.1; p = 0.0037), and for VAS (−1.6; −2.6 to −0.7; p = 0.0030), whereas Group B differed from placebo for SLSD pain level 2 and VAS but not for the SLSD pain level 5. No direct comparison between Groups A and B was statistically significant (all adjusted p > 0.05). After the half-marathon, only Groups B and C showed significant within-group declines in ROM relative to baseline (p = 0.0262 and p = 0.0147), whereas Group A did not (p > 0.99), although between-group ROM contrasts were not significant. Biomarker changes were exploratory, and no between-group biomarker difference reached significance. Conclusions: In this pilot trial, 12 weeks of multi-ingredient supplementation improved pain-limited knee load tolerance and self-reported knee pain relative to placebo in endurance-trained adults. These results require confirmation in a larger trial.

  • Open Access

    Synergistic Effects of Nutritional Formula on Joint Inflammation Through Modulation of Bone Metabolism in Rats

    by Haitao Wang, Yi Wang, Dancai Fan, Zhenhua Niu, Hongming Su, Ang Li, Ruixin Kou, Ziyi Yue, Sihao Wu, Huan Lv, et al.

    Background: Joint inflammation is significantly connected with progressive joint deterioration, potentially increasing the incidence of persistent major clinical challenges and global disability. Nutrient-based preventive strategies have been explored to investigate the interventive efficacy of the proposed prescribed formula for joint inflammation. However, the synergistic ameliorative effects of the nutritional formula should be evaluated to investigate its impact on joint inflammation. Methods: A prescribed formula including turmeric (T), N-acetylglucosamine (G), enzymatically hydrolyzed bone powder (E), and undenatured type II collagen (U) was comprehensively evaluated for its synergistic effects on joint inflammation and the underlying mechanisms. A rat model established using the Hulth method was used to evaluate the interventive effects in vivo. Moreover, in vitro analysis using the murine chondrogenic cell line ATDC5 was performed to validate the intervention and its mechanism of action. Results: The prescribed formula was shown to synergistically reduce levels of inflammation-related cytokines, reduce oxidative stress, and enhance bone metabolism to promote joint regeneration. Micro-Computed Tomography (Micro-CT) analysis revealed restoration of joint architecture and ameliorated physiological status upon formula intervention. In vitro analysis further validated the synergistic alleviation of inflammation and oxidation, as well as reductions in MMP13 and CTX-1 levels, which implies that modulating bone metabolism alleviates the deterioration and inflammation of joint architecture. Conclusions: The synergistic formula in this study achieves synchronous modulation of several core pathological pathways, yielding synergistic modulation of joint inflammation. Nutrient-based interventions or preventive strategies show promising effects against joint inflammation and progressive mechanistic deterioration.